Are you Dr. Bar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 21 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-520-5000Fax+1 206-598-6963- Is this information wrong?
Summary
- Dr. Merav Bar, MD is an oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington and Pennsylvania. She is affiliated with UW Medicine/University of Washington Medical Center and is an Assistant Member at Fred Hutchinson Cancer Research Center.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2004 - 2006- University of WashingtonResidency, Internal Medicine, 2000 - 2003
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1997
Certifications & Licensure
WA State Medical License 2002 - 2022
PA State Medical License 2015 - 2016- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Clinical Trials
- Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation Start of enrollment: 2002 Sep 01
- Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant Start of enrollment: 2012 Dec 01
- Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsTargeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency.Miranda C Lahman, Thomas M Schmitt, Kelly G Paulson, Nathalie Vigneron, Denise Buenrostro, Felecia D Wagener, Valentin Voillet, Lauren Martin, Raphael Gottardo, Jason ...> ;Science Translational Medicine. 2022 Feb 9
- 54 citationsSevere cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy.Krishna R. Juluri, Vicky Wu, Jenna M. Voutsinas, Jue Hou, Alexandre V. Hirayama, Erin Mullane, Nancy Miles, David G. Maloney, Cameron J. Turtle, Merav Bar, Jordan Gaut...> ;Blood Advances. 2021 Oct 19
- 57 citationsStandardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transpla...Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori, Rebecca A. Marsh, Lauri Burroughs, Navneet S. Majhail, A. Samer Al-Homsi, Zaid ...> ;Transplantation and Cellular Therapy. 2021 Aug 1
- Join now to see all
Hospital Affiliations
UW Medicine/University of Washington Medical CenterSeattle, Washington
